Last viewed: EYPT

Prices are updated after-hours

EYPT

EyePoint Pharmaceuticals, Inc.

EYPT | $17.665 0.94% 0.93% 1.5M

|

Health Technology

(0.0% 1d) (-24.6% 1m) (96.1% 1y) (0.0% 2d) (0.0% 3d) (-19.3% 7d) (228.13% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 880,260,941
http://www.eyepointpharma.com
Sec Filling | Patents | 84 employees

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

brands treatment

add to watch list Paper trade email alert is off

Press-releases

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
EYPT | $17.665 0.94% 0.93% 1.5M

|

Health Technology

| -19.26% | O: -4.03% H: 5.43% C: 4.1%
nasdaq pharmaceuticals grants

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
EYPT | $17.665 0.94% 0.93% 1.5M

|

Health Technology

| -12.93% | O: -3.01% H: 4.27% C: 3.15%
retina pharmaceuticals

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Published: 2024-03-18 (Crawled : 11:00) - globenewswire.com
EYPT | $17.665 0.94% 0.93% 1.5M

|

Health Technology

| -17.83% | O: 0.09% H: 1.91% C: -0.93%
nasdaq pharmaceuticals grants

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - March 18, 2024
Published: 2024-03-18 (Crawled : 12:00) - biospace.com/
EYPT | $17.665 0.94% 0.93% 1.5M

|

Health Technology

| -17.83% | O: 0.09% H: 1.91% C: -0.93%
nasdaq pharmaceuticals grants

Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-12 (Crawled : 17:00) - biospace.com/
RLYB | News | $1.75 4.79% 4.57% 310K

|

| -4.35% | O: 1.09% H: 0.0% C: -9.68%
EYPT | $17.665 0.94% 0.93% 1.5M

|

Health Technology

| -22.82% | O: 1.09% H: 3.2% C: -1.34%
year financial results

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M

|

Health Technology

| -4.38% | O: 0.04% H: 0.44% C: -1.51%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -8.07% | O: -2.08% H: 0.13% C: -0.57%
BMY | $48.93 1.3% 0.0% 10M

|

Health Technology

| -8.34% | O: 0.36% H: 0.34% C: -0.54%
XFOR | $1.255 4.58% 4.38% 3M

|

Health Technology

| 30.77% | O: 0.12% H: 0.0% C: -4.98%
EYPT | $17.665 0.94% 0.93% 1.5M

|

Health Technology

| -31.43% | O: 2.56% H: 1.37% C: -4.13%
AQST | $4.11 -8.67% -9.49% 2.3M

|

Health Technology

| -18.29% | O: 1.79% H: 12.3% C: 10.94%
ALKS | $23.86 0.42% 0.42% 2.4M

|

Health Technology

| -17.59% | O: 1.11% H: 0.96% C: 0.65%

EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments
Published: 2024-03-07 (Crawled : 12:00) - globenewswire.com
EYPT | $17.665 0.94% 0.93% 1.5M

|

Health Technology

| -31.43% | O: 2.56% H: 1.37% C: -4.13%
pharmaceuticals financial results

EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
EYPT | $17.665 0.94% 0.93% 1.5M

|

Health Technology

| -36.96% | O: -0.61% H: 0.04% C: -6.9%
pharmaceuticals medical

EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2024
Published: 2024-02-29 (Crawled : 12:00) - globenewswire.com
EYPT | $17.665 0.94% 0.93% 1.5M

|

Health Technology

| -36.24% | O: 1.34% H: 1.0% C: -2.99%
report pharmaceuticals financial

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Published: 2024-02-27 (Crawled : 12:00) - globenewswire.com
EYPT | $17.665 0.94% 0.93% 1.5M

|

Health Technology

| -33.52% | O: 1.58% H: 8.68% C: 6.3%
pharmaceuticals

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001562180-24-003193	4	2024-04-02	2024-03-30	Sell	M	30570	0
0001562180-24-003193	4	2024-04-02	2024-03-30	Sell	F	7096	67080
0001562180-24-003193	4	2024-04-02	2024-03-30	Sell	F	2957	74176
0001562180-24-003193	4	2024-04-02	2024-03-30	Sell	F	15493	77133
0001562180-24-003193	4	2024-04-02	2024-03-30	Buy	M	14000	92626
0001562180-24-003193	4	2024-04-02	2024-03-30	Buy	M	30570	78626
0001562180-24-003193	4	2024-04-02	2024-03-30	Buy	M	5834	48056

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

|

EGOX | $0.0515 43.06% 30.1% 330M

|

OLB 4 | $0.33 -14.95% 25.53% 840K

|

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

|

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

|

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M

|

Distribution Services

INSG | $3.03 25.21% 20.13% 330K

|

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K

|

WLGS | $0.59 18.0% 17.9% 2.3M

|

ASNS | $0.828 21.75% 17.86% 18K

|

Last 48 Hours Insiders Buying

RXO P 200000 | $19.37 2.32% 0.0% 1M

|

| 23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M

|

| 22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K

|

Health Technology

| 22:30
BCDA P 2750 | $0.377 -1.4% 97K

|

Health Technology

| 22:00
RMCF | $3.67 3.38% 3.27% 11K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar